Vitamin D's potential to reduce the risk of hospital-acquired infections

Dermato-Endocrinology

Volumn 4, Issue 2, 2012, Pages 167-175

  Youssef, Dima A ^a   Ranasinghe, Tamra ^b   Grant, William B ^c   Peiris, Alan N ^a  

^a East Tennessee State University   (United States)

^b Research Associate   (United States)

^c Sunlight Nutrition and Health Research Center (SUNARC)   (United States)

Author keywords

Antimicrobials; Deficiency; Economic burden; Hospital acquired infections; Infections; Nosocomial infections; Vitamin D

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN 2; CATHELICIDIN; INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANTIMICROBIAL ACTIVITY; BACTEREMIA; CATHETER INFECTION; CAUSE OF DEATH; CELLULAR IMMUNITY; CLOSTRIDIUM DIFFICILE INFECTION; COST OF ILLNESS; CYTOKINE PRODUCTION; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTHCARE ASSOCIATED INFECTION; HIGH RISK PATIENT; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HOSPITALIZATION COST; HUMAN; HYPOCALCEMIA; IMMUNOMODULATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN INDUCTION; PSEUDOMONAS INFECTION; REVIEW; RISK REDUCTION; SEPSIS; SEPTICEMIA; SOLAR RADIATION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; SURGICAL INFECTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; ULTRAVIOLET B RADIATION; UNITED STATES; URINARY TRACT INFECTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84865165498     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.20789     Document Type: Review

References (118)

1. Welsh CA, Flanagan ME, Hoke SC, Doebbeling BN, Herwaldt L, Agency for Healthcare Research and Quality Hospital-Acquired Infections Collaborative. Reducing health care-associated infections (HAIs): lessons learned from a national collaborative of regional HAI programs. Am J Infect Control 2012; 40:29-34; PMID:21775022; http://dx.doi.org/10.1016/j.ajic.2011.02.017
2. Sprague L. Health care-associated infections: is there an end in sight? Issue Brief Natl Health Policy Forum 2009; •••:1-14; PMID:19343832
3. Klevens RM, Edwards JR, Richards CL, Jr., Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007; 122:160-6; PMID: 17357358
4. Scott, R.D. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. (Publication No. CS200891-A). Centers for Disease Control and Prevention.
5. Roberts RR, Scott RD, 2nd, Hota B, Kampe LM, Abbasi F, Schabowski S, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010; 48:1026-35; PMID:20940650; http://dx.doi.org/10.1097/MLR.0b013e3181ef60a2
6. Glance LG, Stone PW, Mukamel DB, Dick AW. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg 2011; 146:794-801; PMID: 21422331; http://dx.doi.org/10. 1001/archsurg.2011.41
7. Karagozian R, Johannes RS, Sun X, Burakoff R. Increased mortality and length of stay among patients with inflammatory bowel disease and hospital-acquired infections. Clin Gastroenterol Hepatol 2010; 8:961-5; PMID:20723618; http://dx.doi.org/10.1016/j.cgh.2010.07.017
8. Higgins RD, Baker CJ, Raju TN. Executive summary of the workshop on infection in the high-risk infant. J Perinatol 2010; 30:379-83; PMID:20072133; http://dx.doi.org/10.1038/jp.2009.199
9. Flanagan ME, Welsh CA, Kiess C, Hoke S, Doebbeling BN, Agency for Healthcare Research and Quality Hospital-Acquired Infections Collaborative. A national collaborative for reducing health care-associated infections: current initiatives, challenges, and opportunities. Am J Infect Control 2011; 39:685-9; PMID: 21665329; http://dx.doi.org/10.1016/j.ajic.2010.12.013
10. Haber M, Levin BR, Kramarz P. Antibiotic control of antibiotic resistance in hospitals: a simulation study. BMC Infect Dis 2010; 10:254; PMID:20738872; http://dx.doi.org/10.1186/1471-2334-10-254
11. Biddle C. Semmelweis revisited: hand hygiene and nosocomial disease transmission in the anesthesia workstation. AANA J 2009; 77:229-37; PMID: 19645173
12. Feindt E, Ströder J. [Studies on the antimicrobial effect of vitamin D (author's transl)]. Klin Wochenschr 1977; 55:507-8; PMID:195120; http://dx.doi.org/10.1007/BF01489010
13. Toubi E, Shoenfeld Y. The role of vitamin D in regulating immune responses. Isr Med Assoc J 2010; 12:174-5; PMID:20684184
14. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 2009; 4:1151-65; PMID:19895218; http://dx.doi.org/10.2217/fmb.09.87
15. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004; 215:31-8; PMID:15026172; http://dx.doi.org/10.1016/j.mce.2003.11.017
16. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008; 17:348-52; PMID:18660668; http://dx.doi.org/10.1097/MNH.0b013e3282ff64a3
17. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8; PMID:10666315; http://dx.doi.org/10.1006/abbi.1999.1605
18. Eleftheriadis T, Antoniadi G, Liakopoulos V, Galaktidou G. The effect of paricalcitol on osteoprotegerin production by human peripheral blood mononuclear cells. J Rheumatol 2009; 36:856-7; PMID: 19342729; http://dx.doi.org/10.3899/ jrheum.080987
19. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8; PMID:10666315; http://dx.doi.org/10.1006/abbi.1999.1605
20. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66:5314-21; PMID: 9784538
21. Lorente F, Fontan G, Jara P, Casas C, Garcia-Rodriguez MC, Ojeda JA. Defective neutrophil motility in hypovitaminosis D rickets. Acta Paediatr Scand 1976; 65:695-9; PMID:187003
22. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28; PMID:19389235; http://dx.doi.org/10.1186/1479-5876-7-28
23. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001; 145:351-7; PMID:11517017; http://dx.doi.org/10.1530/eje.0.1450351
24. Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 2010; 8:1359-69; PMID:21133662; http://dx.doi.org/10.1586/ eri.10.102
25. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 2011; 6:e25333; PMID:22031815; http://dx.doi.org/10.1371/journal.pone.0025333
26. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117:91-7; PMID:11442754; http://dx.doi.org/10.1046/j.1523-1747.2001.01340.x
27. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-7; PMID:11719807; http://dx.doi.org/10.1038/ 35106587
28. Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 2005; 73:6771-81; PMID:16177355; http://dx.doi.org/10.1128/IAI.73. 10.6771-6781.2005
29. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sørensen O, Borregaard N, et al. The cathelicidin anti-microbial peptide LL-37 is involved in reepithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003; 120:379-89; PMID:12603850; http://dx.doi.org/10.1046/j.1523-1747.2003.12069.x
30. Johansson L, Thulin P, Sendi P, Hertzén E, Linder A, Akesson P, et al. Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 2008; 76:3399-404; PMID:18490458; http://dx.doi.org/10. 1128/IAI.01392-07
31. Lee PH, Ohtake T, Zaiou M, Murakami M, Rudisill JA, Lin KH, et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci U S A 2005; 102:3750-5; PMID:15728389; http://dx.doi.org/10.1073/pnas.0500268102
32. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360:1912-4; PMID:19403914; http://dx.doi.org/10. 1056/NEJMc0809996
33. Bowdish DM, Davidson DJ, Hancock RE. Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 2006; 306:27-66; PMID:16909917; http://dx.doi.org/10.1007/3-540-29916-5-2
34. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55:96-108; PMID:20824663; http://dx.doi.org/10.1002/mnfr.201000174
35. Routsias JG, Karagounis P, Parvulesku G, Legakis NJ, Tsakris A. In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains. Peptides 2010; 31:1654-60; PMID:20600430; http://dx.doi.org/10.1016/j.peptides. 2010.06.010
36. Suzuki Y, Inokuchi S, Takazawa K, Umezawa K, Saito T, Kidokoro M, et al. Introduction of human β-defensin-3 into cultured human keratinocytes and fibroblasts by infection of a recombinant adenovirus vector. Burns 2011; 37:109-16; PMID:20884123; http://dx.doi.org/10.1016/j.burns.2010.08.004
37. Zanger P, Holzer J, Schleucher R, Scherbaum H, Schittek B, Gabrysch S. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect Immun 2010; 78:3112-7; PMID: 20404083; http://dx.doi.org/10.1128/IAI.00078-10
38. Gao N, Kumar A, Jyot J, Yu FS. Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. PLoS One 2010; 5:e9351; PMID:20195469; http://dx.doi.org/10.1371/journal.pone.0009351
39. Vähävihu K, Ala-Houhala M, Peric M, Karisola P, Kautiainen H, Hasan T, et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 2010; 163:321-8; PMID:20331450; http://dx.doi.org/10.1111/j.1365-2133.2010.09767.x
40. Youssef D, Miller C, El-Abbassi A, Cutchins D, Cutchins C, Grant WB, et al. Antimicrobial implications of vitamin D. Dermatoendocrinol 2011; 3:1-10; PMID:21519401; http://dx.doi.org/10.4161/derm.3.4.15027
41. Youssef D, Bailey B, El Abbassi A, Copeland R, Adebonojo L, Manning T, et al. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect 2010; 138:1322-7; PMID:20056018; http://dx.doi.org/10.1017/S0950268809991543
42. Youssef D, Bailey B, El-Abbassi A, Vannoy M, Manning T, Moorman JP, et al. Healthcare costs of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa infections in veterans: role of vitamin D deficiency. Eur J Clin Microbiol Infect Dis 2012; 31:281-6; PMID:21695580; http://dx.doi.org/ 10.1007/s10096-011-1308-9
43. McKinney JD, Bailey BA, Garrett LH, Peiris P, Manning T, Peiris AN. Relationship between vitamin D status and ICU outcomes in veterans. J Am Med Dir Assoc 2011; 12:208-11; PMID:21333923; http://dx.doi.org/10.1016/j.jamda.2010. 04.004
44. Higgins DM, Wischmeyer PE, Queensland KM, Sillau SH, Sufit AJ, Heyland DK. Relationship of Vitamin D Deficiency to Clinical Outcomes in Critically Ill Patients. [Epub ahead of print]. JPEN J Parenter Enteral Nutr 2012; PMID:22523178; http://dx.doi.org/10.1177/0148607112444449
45. Grant WB. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol 2009; 1:37-42; PMID:20046587; http://dx.doi.org/10.4161/derm.1.1.7250
46. Grant WB. Vitamin D supplementation of mother and infant could reduce risk of sepsis in premature infants. Early Hum Dev 2010; 86:133; PMID:20188500; http://dx.doi.org/10.1016/j.earlhumdev.2010.02.003
47. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28; PMID:19389235; http://dx.doi.org/10.1186/1479-5876-7-28
48. Watkins RR, Yamshchikov AV, Lemonovich TL, Salata RA. The role of vitamin D deficiency in sepsis and potential therapeutic implications. J Infect 2011; 63:321-6; PMID:21777617; http://dx.doi.org/10.1016/j.jinf.2011.07.002
49. Shea MK, Houston DK, Tooze JA, Davis CC, Johnson MA, Hausman DB, et al. Health, Aging and Body Composition Study. Correlates and prevalence of insufficient 25-hydroxyvitamin D status in black and white older adults: the health, aging and body composition study. J Am Geriatr Soc 2011; 59:1165-74; PMID:21668915; http://dx.doi.org/10.1111/j.1532-5415.2011.03476.x
50. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc 2010; 11:617-28; PMID:21029996; http://dx.doi.org/10.1016/j.jamda.2010.03.013
51. Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA 2010; 303:2495-503; PMID:20571016; http://dx.doi.org/10.1001/jama.2010.851
52. Ranji SR, Steinman MA, Shojania KG, Gonzales R. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Med Care 2008; 46:847-62; PMID:18665065; http://dx.doi.org/10.1097/ MLR.0b013e318178eabd
53. Hill AB. The Environment and Disease: Association or Causation? Proc R Soc Med 1965; 58:295-300; PMID:14283879
54. Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol 2009; 1:17-24; PMID:20046584; http://dx.doi.org/10. 4161/derm.1.1.7388
55. Grant WB, Boucher BJ. Are Hill's criteria for causality satisfied for vitamin D and periodontal disease? Dermatoendocrinol 2010; 2:30-6; PMID:21547146; http://dx.doi.org/10.4161/derm.2.1.12488
56. Marschall J, Fraser VJ, Doherty J, Warren DK. Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients. Infect Control Hosp Epidemiol 2009; 30:1050-6; PMID: 19803723; http://dx.doi.org/10.1086/606165
57. Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 2005; 84:303-12; PMID:16148730; http://dx.doi.org/10.1097/01.md.0000180045.26909.29
58. Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect 2006; 63:124-32; PMID:16621137; http://dx.doi.org/10.1016/j.jhin.2005.12.016
59. Agency for Healthcare Research and Quality. "Blood Infections Most Costly Hospital Condition." Medical News Today. MediLexicon, Intl., 7 Oct. 2011. Web. 10 Nov. 2011.
60. White AN, Ng V, Spain CV, Johnson CC, Kinlin LM, Fisman DN. Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania. BMC Infect Dis 2009; 9:196; PMID:19961583; http://dx.doi.org/10.1186/1471-2334-9-196
61. Vanholder R, Van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20:477-80; PMID:12207097; http://dx.doi.org/10.1159/000063556
62. Zaloga GP, Chernow B, Cook D, Snyder R, Clapper M, O'Brian JT. Assessment of calcium homeostasis in the critically ill surgical patient. The diagnostic pitfalls of the McLean-Hastings nomogram. Ann Surg 1985; 202:587-94; PMID:4051606; http://dx.doi.org/10.1097/00000658-198511000-00009
63. Lee P, Campbell LV. Vitamin D deficiency: the invisible accomplice of metabolic endotoxemia? Curr Pharm Des 2009; 15:2751-8; PMID:19689344; http://dx.doi.org/10.2174/138161209788923895
64. Amin A, Kollef MH. Health care-associated pneumonia. Hosp Pract (Minneap) 2010; 38:63-74; PMID: 20499775; http://dx.doi.org/10.3810/hp.2010.06.317
65. Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 2006; 243:547-52; PMID:16552208; http://dx.doi.org/10.1097/01.sla. 0000207097.38963.3b
66. Vayalumkal JV, Gravel D, Moore D, Matlow A, Canadian Nosocomial Infection Surveillance Program. Surveillance for healthcare-acquired febrile respiratory infection in pediatric hospitals participating in the Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol 2009; 30:652-8; PMID:19496653; http://dx.doi.org/10.1086/598247
67. Brown SM, Waterer GW. Vitamin D: stronger lungs as well as stronger bones? Respirology 2011; 16:577-8; PMID:21306477; http://dx.doi.org/10.1111/j. 1440-1843.2011.01947.x
68. Leow L, Simpson T, Cursons R, Karalus N, Hancox RJ. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 2011; 16:611-6; PMID:21244571; http://dx.doi.org/10.1111/j.1440-1843.2011.01924.x
69. Inamo Y, Hasegawa M, Saito K, Hayashi R, Ishikawa T, Yoshino Y, et al. Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr Int 2011; 53:199-201; PMID:21648117; http://dx.doi.org/10.1111/j.1442-200X.2010. 03224.x
70. Oduwole AO, Renner JK, Disu E, Ibitoye E, Emokpae E. Relationship between vitamin D levels and outcome of pneumonia in children. West Afr J Med 2010; 29:373-8; PMID:21465443
71. Banajeh SM. Nutritional rickets and vitamin D deficiency-association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr Pulmonol 2009; 44:1207-15; PMID: 19911367; http://dx.doi.org/10.1002/ ppul.21121
72. Sundar IK, Rahman I. Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol 2011; 2:50; PMID:21941510; http://dx.doi.org/10.3389/fphar.2011.00050
73. Rubin BK, Dhand R, Ruppel GL, Branson RD, Hess DR. Respiratory care year in review 2010: part 1. asthma, COPD, pulmonary function testing, ventilator-associated pneumonia. Respir Care 2011; 56:488-502; PMID:21496376; http://dx.doi.org/10.4187/respcare.01286
74. Choudhary N, Gupta P, Vitamin D. Vitamin D Supplementation for Severe Pneumonia A Randomized Controlled Trial. Indian Pediatr 2011; PMID: 21992858
75. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-40; PMID:16959053; http://dx.doi.org/10.1017/S0950268806007175
76. Goldstein MR, Mascitelli L, Pezzetta F. Pandemic influenza A (H1N1): mandatory vitamin D supplementation? Med Hypotheses 2010; 74:756; PMID: 20006449; http://dx.doi.org/10.1016/j.mehy.2009.11.006
77. Juzeniene A, Ma LW, Kwitniewski M, Polev GA, Lagunova Z, Dahlback A, et al. The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int J Infect Dis 2010; 14:e1099-105; PMID:21036090; http://dx.doi.org/10.1016/j.ijid.2010.09.002
78. Hayes DP. Influenza pandemics, solar activity cycles, and vitamin D. Med Hypotheses 2010; 74:831-4; PMID:20056531; http://dx.doi.org/10.1016/j.mehy.2009. 12.002
79. Grant WB, Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol 2009; 1:215-9; PMID:20592793; http://dx.doi.org/10.4161/derm.1.4.9063
80. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91:1255-60; PMID:20219962; http://dx.doi.org/10.3945/ajcn.2009.29094
81. Shaman J, Jeon CY, Giovannucci E, Lipsitch M. Shortcomings of vitamin D-based model simulations of seasonal influenza. PLoS One 2011; 6:e20743; PMID:21677774; http://dx.doi.org/10.1371/journal.pone.0020743
82. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007; 28:1219-27; PMID:17926270; http://dx.doi.org/10.1086/522676
83. Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008; 29:823-8; PMID:18643746; http://dx.doi.org/10.1086/588756
84. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30:57-66; PMID:19049438; http://dx.doi.org/10.1086/592981
85. Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol Aspects Med 2012; 33:77-82; PMID:22079836; http://dx.doi.org/10.1016/j.mam.2011.10.014
86. S Tulk, S Hirota, J MacDonald, P Beck. Vitamin D downregulates NLRP3 and protects against Clostridium difficile toxin-induced cell death. University of Calgary, Calgary, AB.
87. Arramraju S, et al "Higher resolution rate of clostridia difficile enteritis in hospitalized patients with normal vitamin D levels" DDW 2010; Abstract T1793.
88. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000; 28:68-75; PMID:10679141; http://dx.doi.org/10.1016/S0196-6553(00)90015-4
89. Gray M. Reducing catheter-associated urinary tract infection in the critical care unit. AACN Adv Crit Care 2010; 21:247-57; PMID:20683224; http://dx.doi.org/10.1097/NCI.0b013e3181db53cb
90. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55:96-108; PMID: 20824663; http://dx.doi.org/10.1002/mnfr.201000174
91. Aslan S, Akil I, Aslan G, Onay H, Ozyurt BC, Ozkinay F. Vitamin D receptor gene polymorphism in children with urinary tract infection. Pediatr Nephrol 2012; 27:417-21; PMID:21947233; http://dx.doi.org/10.1007/s00467-011- 2000-0
92. Hertting O, Holm Å, Lüthje P, Brauner H, Dyrdak R, Jonasson AF, et al. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One 2010; 5:e15580; PMID:21179490; http://dx.doi.org/10.1371/journal.pone.0015580
93. Felkner M, Pascoe N, Shupe-Ricksecker K, Goodman E. The wound care team: a new source of group a streptococcal nosocomial transmission. Infect Control Hosp Epidemiol 2005; 26:462-5; PMID:15954484; http://dx.doi.org/10.1086/502568
94. Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V. Surgical site infections: Causative pathogens and associated outcomes. Am J Infect Control 2010; 38:112-20; PMID:19889474; http://dx.doi.org/10.1016/j.ajic.2009.06.010
95. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60; PMID:12374875; http://dx.doi.org/10.1056/ NEJMoa021481
96. Hiemstra PS. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp Lung Res 2007; 33:537-42; PMID:18075828; http://dx.doi.org/10.1080/01902140701756687
97. White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol 2010; 121:234-8; PMID:20302931; http://dx.doi.org/10.1016/j.jsbmb.2010.03.034
98. Arnold WP, van de Kerkhof PC. The induction of epidermal ornithine decarboxylase following tape stripping is inhibited by a topical vitamin D3 analogue (MC903). Br J Dermatol 1991; 125:6-8; PMID: 1873206; http://dx.doi.org/10.1111/j.1365-2133.1991.tb06029.x
99. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, et al. The impact of vitamin D status on periodontal surgery outcomes. J Dent Res 2011; 90:1007-12; PMID:21555774; http://dx.doi.org/10.1177/0022034511407771
100. George MH, Heinrich PE, Dexter DR, Morgan JB, Odde KG, Glock RD, et al. Injection-site lesions in carcasses of cattle receiving injections at branding and at weaning. J Anim Sci 1995; 73:3235-40; PMID: 8586578
101. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71; PMID: 17940231; http://dx.doi.org/10.1001/jama.298.15. 1763
102. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46(Suppl 5):S378-85; PMID: 18462093; http://dx.doi.org/10.1086/533594
103. Niven DJ, Laupland KB, Gregson DB, Church DL, S aureus Screening Initiative Group. Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill. J Crit Care 2009; 24:583-9; PMID:19327313; http://dx.doi.org/10.1016/j.jcrc.2008.10.004
104. Matheson EM, Mainous AG, 3rd, Hueston WJ, Diaz VA, Everett CJ. Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis 2010; 42:455-60; PMID:20210515; http://dx.doi.org/10.3109/00365541003602049
105. Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study. Eur J Clin Microbiol Infect Dis 2012; 31:465-73; PMID:21811869; http://dx.doi.org/10.1007/s10096-011-1331-x
106. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167:1730-7; PMID:17846391; http://dx.doi.org/10.1001/archinte.167.16.1730
107. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91-100; PMID:22170374; http://dx.doi.org/10.3945/ajcn.111.014779
108. Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011; 65:1016-26; PMID:21731036; http://dx.doi.org/10.1038/ejcn.2011.68
109. Schöttker B, Ball D, Gellert C, Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev. 2012 Feb 16. [Epub ahead of print] (in print in July)
110. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-8; PMID: 21118827; http://dx.doi.org/10.1210/jc.2010-2704
111. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135:317-22; PMID:15671234
112. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011; 31:607-11; PMID: 21378345
113. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 2010; 235:1034-45; PMID:20667908; http://dx.doi.org/10.1258/ebm.2010.010014
114. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30; PMID:21646368; http://dx.doi.org/10.1210/jc.2011-0385
115. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9:709-15; PMID: 20601202; http://dx.doi.org/10.1016/j.autrev.2010.06.009
116. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010; 5: e11088; PMID:20559424; http://dx.doi.org/10.1371/journal.pone.0011088
117. Youssef DA, El Abbassi AM, Cutchins DC, Chhabra S, Peiris AN. Vitamin D deficiency: implications for acute care in the elderly and in patients with chronic illness. Geriatr Gerontol Int 2011; 11:395-407; PMID:21605301; http://dx.doi.org/10.1111/j.1447-0594.2011.00716.x
118. Cannell J. Bio-Tech 50,000 IU D3 now available for prescription. 28 Feb 2012. http://www.vitamindcouncil.org/bio-tech-50000-iu-d3-now-available-for- prescription/